Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Gene Therapy Market: By Indication: Neurological Disorder, Oncological Disorders, Rare Diseases, Eye Disorders, Other; By Vector: Non-Viral Vector, Viral Vector; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments

Global Gene Therapy Market Outlook

The global gene therapy market reached a value of around USD 5.15 billion in 2021. The market is further estimated to grow in the forecast period of 2023-2028 at a CAGR of 22.80% to reach about USD 17.67 billion by 2027.

 

Increasing Applications of Viral Vectors in Gene Therapy for the Treatment of Chronic Diseases Driving the Market Growth

The increasing applications of viral vectors in gene therapy for the treatment of neurological, metabolic, and neurodegeneration diseases are driving the segment growth. With viral vectors offering various favourable properties such as safety, low-toxicity, and excellent stability, they are increasingly preferred in gene therapy. As adenoviruses have excellent DNA harbouring capacity, they are one of the most extensively applied viral vectors in gene therapy. They are also used for the development of vaccines and cancer therapies, hence fuelling the growth of the gene therapy market.

Viral vectors account for a significant share in the clinical trials of gene therapy owing to their efficiency to deliver genes to the target tissues/cells. The increasing regulatory approvals of gene therapy drugs based on viral vectors are further propelling the market. Over the forecast period, the emergence of Adeno-associated virus vectors (AAV) as a gene therapy platform for the treatment of neurological diseases is likely to propel the growth of the overall market.

 

North America Accounts for a Significant Share in the Market for Gene Therapy

The gene therapy market in North America is being driven by the growing healthcare expenditure in the region and a strong foothold of major biopharmaceutical companies focused on advancing gene therapy techniques. The growing prevalence of health issues such as cancer and cystic fibrosis in the region is further propelling the demand for gene therapy. In addition, the surging initiation of gene therapy clinical trials in the region to develop effective treatments for chronic diseases is augmenting the market. Moreover, the introduction of various favourable initiatives by governments to encourage innovations and advancements in gene therapy is likely to propel the market expansion. The surging approval rates of new gene therapies by health authorities to expand therapeutic treatment choices are expected to further aid the market in the forecast period.

 

Market Segmentation

Gene therapy is defined as a medical approach that targets the genetic problem of a patient in order to treat or prevent diseases. In this treatment therapy, a person’s genetic make-up is altered or modified instead of using drugs or surgery. Several mechanisms, including the replacement of disease-causing genes, inactivation of a disease-causing gene, and introduction of a modified gene into the body, among others, are involved in this process.

Based on indication, the market can be segmented into:

  • Neurological Disorder
  • Oncological Disorders
  • Rare Diseases
  • Eye Disorders
  • Others

By vector, the market is divided into:

  • Non-Viral Vector
    • Oligonucleotides 
    • Others
  • Viral Vector 
    • Retroviral Vectors
    • Adeno-associated Viral Vectors
    • Others

The EMR report looks into the regional markets of gene therapy like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Emergence of Gene Therapy as a Promising Treatment Option for Various Diseases to Boost the Market Growth

The emergence of gene therapy techniques as a promising treatment option for various genetic diseases such as muscular dystrophy and cystic fibrosis, among others, is driving the market growth. The emerging treatment modalities, such as immunotherapy and oncolytic virotherapy, are increasingly gaining traction in cancer treatments. In addition to this, the increasing prevalence of cancer, coupled with the robust research and development activities aimed at expanding the cancer treatment options, is likely to accelerate the growth of the gene therapy market in the coming years. As cancer treatment options based on gene therapy offer a high success rate and enhanced flexibility, the market is expected to witness a healthy growth.

Gene therapy offers a possibility of a positive medical outcome and can create permanent results, which is strengthening the market growth. Over the forecast period, the increasing approvals of various gene therapy medications such as Zolgensma by health authorities like the Food and Drug Administration of the United States (FDA) are expected to bolster the market growth. Moreover, the evolving patient preference toward minimally invasive treatment procedures for diseases like Lymphoma and Leukaemia, among others, is anticipated to propel the gene therapy market growth in the coming years.

 

Key Players in the Global Market for Gene Therapy

The report gives a detailed analysis of the following key players in the global gene therapy market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Novartis AG
  • Amgen Inc.
  • bluebird bio, Inc.
  • Biogen Inc.
  • Sibiono GeneTech Co. Ltd.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Indication
  • Vector
  • Region
Breakup by Indication
  • Neurological Disorder
  • Oncological Disorders
  • Rare Diseases
  • Eye Disorders
  • Others
Breakup by Vector
  • Non-Viral Vector
    • Oligonucleotides 
    • Others
  • Viral Vector 
    • Retroviral Vectors
    • Adeno-associated Viral Vectors
    • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Novartis AG
  • Amgen Inc.
  • bluebird bio, Inc.
  • Biogen Inc.
  • Sibiono GeneTech Co. Ltd.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Gene Therapy Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Gene Therapy Historical Market (2018-2022) 
    8.3    Global Gene Therapy Market Forecast (2023-2028)
    8.4    Global Gene Therapy Market by Indication
        8.4.1    Neurological Disorder
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Oncological Disorders
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
        8.4.3    Rare Diseases
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2022)
            8.4.3.3    Forecast Trend (2023-2028)
        8.4.4    Eye Disorders
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2018-2022)
            8.4.4.3    Forecast Trend (2023-2028)
        8.4.5    Other
    8.5    Global Gene Therapy Market by Vector
        8.5.1    Non-Viral Vector
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
            8.5.1.4    Breakup by Type
                8.5.1.4.1    Oligonucleotides 
                8.5.1.4.2    Others
        8.5.2    Viral Vector
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
            8.5.2.4    Breakup by Type
                8.5.2.4.1    Retroviral Vectors
                8.5.2.4.2    Adeno-associated Viral Vectors
                8.5.2.4.3    Others
    8.6    Global Gene Therapy Market by Region       
        8.6.1    North America
           8.6.1.1    Market Share
           8.6.1.2    Historical Trend (2018-2022) 
           8.6.1.3    Forecast Trend (2023-2028)
       8.6.2    Europe
           8.6.2.1    Market Share
           8.6.2.2    Historical Trend (2018-2022) 
           8.6.2.3    Forecast Trend (2023-2028)
       8.6.3    Asia Pacific
           8.6.3.1    Market Share
           8.6.3.2    Historical Trend (2018-2022) 
           8.6.3.3    Forecast Trend (2023-2028)
       8.6.4    Latin America
           8.6.4.1    Market Share
           8.6.4.2    Historical Trend (2018-2022) 
           8.6.4.3    Forecast Trend (2023-2028)
       8.6.5    Middle East and Africa
           8.6.5.1    Market Share
           8.6.5.2    Historical Trend (2018-2022) 
           8.6.5.3    Forecast Trend (2023-2028)
9    North America Gene Therapy Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2022) 
        9.1.3    Forecast Trend (2023-2028)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2022) 
        9.2.3    Forecast Trend (2023-2028)
10    Europe Gene Therapy Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2022) 
        10.1.3    Forecast Trend (2023-2028)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2022) 
        10.2.3    Forecast Trend (2023-2028)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2022) 
        10.3.3    Forecast Trend (2023-2028)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2022) 
        10.4.3    Forecast Trend (2023-2028)
    10.5    Others
11    Asia Pacific Gene Therapy Market Analysis
    11.1    China    
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2022) 
        11.1.3    Forecast Trend (2023-2028)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2022) 
        11.2.3    Forecast Trend (2023-2028)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2022) 
        11.3.3    Forecast Trend (2023-2028)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2022) 
        11.4.3    Forecast Trend (2023-2028)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2022) 
        11.5.3    Forecast Trend (2023-2028)
    11.6    Others
12    Latin America Gene Therapy Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2022) 
        12.1.3    Forecast Trend (2023-2028)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2022) 
        12.2.3    Forecast Trend (2023-2028)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2022) 
        12.3.3    Forecast Trend (2023-2028)
    12.4    Others
13    Middle East and Africa Gene Therapy Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2022) 
        13.1.3    Forecast Trend (2023-2028)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2022) 
        13.2.3    Forecast Trend (2023-2028)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2022) 
        13.3.3    Forecast Trend (2023-2028)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2022) 
        13.4.3    Forecast Trend (2023-2028)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Novartis AG
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Amgen Inc.
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    bluebird bio, Inc.
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Biogen Inc.
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Sibiono GeneTech Co. Ltd.
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Others
16    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Gene Therapy Market: Key Industry Highlights, 2017 and 2021
2.    Global Gene Therapy Historical Market: Breakup by Indication (USD Billion), 2018-2022
3.    Global Gene Therapy Market Forecast: Breakup by Indication (USD Billion), 2023-2028
4.    Global Gene Therapy Historical Market: Breakup by Vector (USD Billion), 2018-2022
5.    Global Gene Therapy Market Forecast: Breakup by Vector (USD Billion), 2023-2028
6.    Global Gene Therapy Historical Market: Breakup by Region (USD Billion), 2018-2022
7.    Global Gene Therapy Market Forecast: Breakup by Region (USD Billion), 2023-2028
8.    North America Gene Therapy Historical Market: Breakup by Country (USD Billion), 2018-2022
9.    North America Gene Therapy Market Forecast: Breakup by Country (USD Billion), 2023-2028
10.    Europe Gene Therapy Historical Market: Breakup by Country (USD Billion), 2018-2022
11.    Europe Gene Therapy Market Forecast: Breakup by Country (USD Billion), 2023-2028
12.    Asia Pacific Gene Therapy Historical Market: Breakup by Country (USD Billion), 2018-2022
13.    Asia Pacific Gene Therapy Market Forecast: Breakup by Country (USD Billion), 2023-2028
14.    Latin America Gene Therapy Historical Market: Breakup by Country (USD Billion), 2018-2022
15.    Latin America Gene Therapy Market Forecast: Breakup by Country (USD Billion), 2023-2028
16.    Middle East and Africa Gene Therapy Historical Market: Breakup by Country (USD Billion), 2018-2022
17.    Middle East and Africa Gene Therapy Market Forecast: Breakup by Country (USD Billion), 2023-2028
18.    Global Gene Therapy Market Structure

Key Questions Answered in the Report

In 2021, the global gene therapy market attained a value of nearly USD 5.15 billion.

The market is estimated to grow at a CAGR of 22.80% between 2023 and 2028.

The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach about USD 17.67 billion by 2027.

The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major drivers of the market include the increasing prevalence of chronic diseases, the growing approvals of gene therapy medications by health authorities, and the increasing inclination towards minimally invasive treatment procedures.

The growing research and development (R&D) activities by the major biopharmaceutical companies to expand gene therapy treatment options, the surging prevalence of cancer, and the growing initiation of gene therapy clinical trials.

Neurological disorder, oncological disorders, rare diseases, and eye disorders, among others, are the different indication segments of gene therapy.

Non-viral vector and viral vector are the significant vectors of gene therapy in the market.

The major players in the market are Novartis AG, Amgen Inc., bluebird bio, Inc., Biogen Inc., and Sibiono GeneTech Co. Ltd., among others.

Analyst Review

The global gene therapy market reached a value of about USD 5.15 billion in 2021, driven by the rising healthcare expenditure. Aided by the growing research and development (R&D) activities to expand gene therapy treatment options, the market is estimated to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 22.80%, to reach a value of nearly USD 17.67 billion by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on indication, the market for gene therapy is segmented into neurological disorder, oncological disorders, rare diseases, and eye disorders, among others. On the basis of vector, the market is bifurcated into non-viral vector and viral vector. The major regional markets for gene therapy are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Novartis AG, Amgen Inc., bluebird bio, Inc., Biogen Inc., and Sibiono GeneTech Co. Ltd., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER